An Efficacy and Safety Study of Palovarotene for the Treatment of MO
Status:
Terminated
Trial end date:
2020-10-30
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled study comparing the safety and
efficacy of 2 dosage regimens of palovarotene versus placebo in preventing disease
progression in pediatric subjects with multiple osteochondromas (MO).